论文部分内容阅读
目的:观察银杏达莫注射液治疗心脑血管病的最佳用药速度。方法:选择我院2011年1月—2012年1月采用银杏达莫注射液治疗的心脑血管疾病患者156例,随机分成甲、乙、丙三组,每组均52例。三组患者给予不同的用药速度进行治疗,比较三组患者临床症状和副反应的区别。结果:乙组总有效率为96.1%,明显优于甲组与丙组,B组不良反应发生率明显低于甲、乙两组(P均<0.05)。结论:银杏达莫注射液治疗心绞痛疗效确切,值得推广。
OBJECTIVE: To observe the best medication rate of Yinxingdamo injection in the treatment of cardiovascular and cerebrovascular diseases. Methods: A total of 156 patients with cardiovascular and cerebrovascular diseases treated with Yinxingdamo injection from January 2011 to January 2012 in our hospital were randomly divided into three groups (A, B and C), with 52 cases in each group. Three groups of patients given different rates of medication for treatment, comparing the clinical symptoms and side effects of the three groups of patients. Results: The total effective rate in group B was 96.1%, which was significantly better than group A and group C. The incidence of adverse reactions in group B was significantly lower than that in group A and B (all P <0.05). Conclusion: Yinxingdamo injection is effective in treating angina pectoris and is worth promoting.